Silexion Therapeutics Ltd. (SLXN) has a market capitalization of $572.18K and trades at $1.02. The 52-week range is 1.07-22.36.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-8.96.
The stock has a beta of 0.06, operates in the Healthcare sector.
